Clinical Study Results
How many participants had serious adverse reactions?
None of the participants had serious adverse reactions during the study.
None of the participants died due to serious adverse reactions during the study.
How many participants had adverse reactions?
There were 0.6% of participants who had adverse reactions during the study. This
was 2 out of 300 participants.
• 0.4% of participants who got the study vaccine had adverse reactions during the
study. This was 1 out of 240 participants. This participant had throat irritation.
• 1.7% of participants who got the placebo had adverse reactions during the study.
This was 1 out of 60 participants. This participant had nasal itchiness.
Only a single dose of the study vaccine was given. So, no participants stopped
getting the study vaccine because of adverse reactions they had during the study.
How has this study helped patients and
researchers?
These results helped researchers learn more about the safety of MEDI3250
vaccine in healthy participants.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with the MEDI3250 vaccine are planned.
7